Gilead's Kite, Appia Bio in up to $875M development deal on cancer allogenic cell therapies
August 05 2021 - 2:29PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Sep 2023 to Sep 2024